Research Article
Transcatheter Angiographic Embolization of Percutaneous Nephrolithotomy-Related Bleeding: A Single-Center Experience
Table 3
Changes in hemoglobin and hematocrit.
| Hematocrit decrease (g/L), median (IQR) | Bleeding episode to TAE | 10 (6.55, 16.05) | TAE to D1 | 2.8 (1.45, 4.85) | D1 to D3 | 1.9 (0.83, 3.45) |
| Minimum hemoglobin before embolization (g/L), median (IQR) | 89 (72.48, 106) |
| Hemoglobin decrease (g/L), median (IQR) | Bleeding episode to TAE | 52 (25.25, 71.00) | TAE to D1 | 10 (−1, 21) | D1 to D3 | 3.5 (−2.75, 11.00) |
| Hemoglobin decrease rate (g/L·d), median (IQR) | Bleeding episode to TAE | 13.11 (5.60, 26.12) | TAE to D1 | 6.0 (−1.5, 10.75) |
|
|
TAE, transcatheter angiographic embolization; D1, the first post-TAE day; D3, the third post-TAE day.
|